ACTIVE METABOLITES OF NEUROLEPTIC DRUGS - POSSIBLE CONTRIBUTION TO THERAPEUTIC AND TOXIC EFFECTS

被引：70

作者：

DAHL, SG

机构：

来源：

关键词：

D O I：

10.1097/00007691-198204000-00005

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：33 / 40

页数：8

共 43 条

[1] MASS FRAGMENTOGRAPHIC METHOD FOR DETERMINATION OF CHLORPROMAZINE AND 2 OF ITS ACTIVE METABOLITES IN HUMAN-PLASMA AND CSF
ALFREDSSON, G
WODEHELGODT, B
SEDVALL, G
[J]. PSYCHOPHARMACOLOGY, 1976, 48 (02) : 123 - 131
[2] AXELSSON R, 1977, CURR THER RES CLIN E, V21, P587
[3] AXELSSON R, 1977, CURR THER RES CLIN E, V21, P561
[4] AXELSSON R, 1979, BIOL PSYCHIATRY TODA, P955
[5] BYLUND DB, 1981, J PHARMACOL EXP THER, V217, P81
[6] CASPER R, 1980, ARCH GEN PSYCHIAT, V37, P301
[7] NEUROLEPTIC BLOOD-LEVELS AND THERAPEUTIC EFFECT
COHEN, BM
LIPINSKI, JF
POPE, HG
HARRIS, PQ
ALTESMAN, RI
[J]. PSYCHOPHARMACOLOGY, 1980, 70 (02) : 191 - 193
[8] COHEN BM, 1980, PSYCHIAT RES, V1, P173
[9] DETERMINATION OF LOXAPINE IN HUMAN-PLASMA AND URINE AND IDENTIFICATION OF 3 URINARY METABOLITES
COOPER, SF
DUGAL, R
BERTRAND, MJ
[J]. XENOBIOTICA, 1979, 9 (07) : 405 - 414
[10] GLC ANALYSIS OF LOXAPINE, AMOXAPINE, AND THEIR METABOLITES IN SERUM AND URINE
COOPER, TB
KELLY, RG
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (02) : 216 - 219